Stanford University
Showing 451-500 of 829 Results
-
Robert Simoni
Professor, Biology
Current Research and Scholarly InterestsCholesterol in biological membranes; genetic mechanisms & cholesterol production
-
Laura Simons
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
Current Research and Scholarly InterestsI am a Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine and a clinical psychologist who evaluates and treats youth presenting with chronic pain in the Pediatric Pain Management Clinic (PPMC) at Stanford Children’s Health. My program of research aims to utilize a pain neuroscience psychology approach to gain a mechanistic understanding of cognitive and affective processes in pediatric pain, perform rigorous patient-oriented research that translates targeted assessment into mechanistically informed treatment approaches for optimal clinical care and leverage the ubiquity of digital health to enhance patient access and reach. Central to these goals are projects targeting adolescence and youth adults with chronic pain that encompass defining brain signatures of threat interpretation, evaluating the efficacy of graded exposure (NCT03699007), deriving a biosignature of improvement vs. persistence of pain and disability (NCT04285112), and evaluating the impact of virtual reality on pain rehabilitation (NCT04636177). These studies along with additional work examining the journey of pain care for youth with pain and their parents form a comprehensive research portfolio in the realm of understanding and treating chronic pain in young people. My long-term career goal is to lead a robust research program focusing on alleviating the suffering of youth and emerging adults with chronic pain.
-
Barbara G Simpson
Assistant Professor of Civil and Environmental Engineering
BioOur research group is made up of a small team of talented students with a wide range of skills and experience. We explore advanced computational and experimental methods to characterize structural response. Our aim is to develop innovative structural systems that improve structural performance and reduce the effects of natural hazards on the built environment.
Research areas include resilient and sustainable design and retrofit of building structures and offshore renewable energy systems, performance-based earthquake engineering, and next-generation computational modeling, including real-time hybrid simulation for fluid-structure interaction. -
Bob Sinclair
Charles M. Pigott Professor in the School of Engineering
BioUsing high-resolution transmission electron microscopy, Sinclair studies microelectronic and magnetic thin film microstructure.
-
Harminder Singh, M.D.
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsMinimally Invasive Cranial and Spinal Surgery, Endoscopic Keyhole Surgery
-
Kuldev Singh, MD, MPH
Professor of Ophthalmology
Current Research and Scholarly InterestsGlaucoma, clinical epidemiology
-
Sundeep Singh
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioAfter living and training throughout the country, I am excited to be part of the Stanford team. As a result of both my personal experiences and training, I am passionate about ensuring that patients receive appropriate diagnostic testing and treatment options in order to improve people's quality of life. In collaboration with my amazing colleagues, I am confident in the high quality and easily accessible care we are able to provide to patients across northern California.
While my interest is most in inflammatory bowel disease, I am also interested in the interaction between mental health, incentives, and emerging therapies in gastroenterology. -
Upinder Singh
Stanford Medicine Professor of Infectious Disease and Professor of Medicine (Infectious Diseases & Geographic Medicine) and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.
-
Vanila M. Singh, MD MACM
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr Singh is the immediate past Chief Medical Officer in the US Department of Health and Human Services and was Chairperson of the highly regarded HHS Task Force in conjunction with the Department of Defense and the Veterans Affairs. She led this group to the comprehensive and approachable final report submitted to Congress. She is a clinical associate professor of Anesthesiology, Pain and Peri-operative Medicine at Stanford and is a teaching mentor at Walter Reed National Military Medical Center.
Pain Management Best Practices HHS Task Force Report: https://www.hhs.gov/sites/default/files/pain-mgmt-best-practices-draft-final-report-05062019.pdf
The Best Practices Pain Inter-agency report that was convened by US Department of HHS in conjunction with Department of Defense and the Veterans Administration is supported by over 160 organizations including the Human Rights Watch, dozens of patient advocacy groups, respected medical organizations including AMA, AAOS, AAPS, ASA, CMA, ASIPP, AAPM, ACOG, CSNS, and dozens of others and key stakeholders such as nursing, social workers, integrative health primary physicians pharmacists and others. There were over 10,000 public comments highlighting the challenges that forced tapering of opioids and the abandonment of chronic pain patients across the nation. The significant patient harms have been a topic of concern with the resulting number of suicides and adverse clinical outcomes pushing patients to the medically unsupervised black market.
Dr Singh has a background in molecular and cell biology, economics, pain medicine, and regional anesthesia with a forte in advanced ultrasound guided procedures for pain and anesthesia medicine. She is double board-certified in pain and anesthesiology. She has served in medical ethics, and to served on scientific editorial boards, committees for the American Society of Regional Anesthesia, American Society of Interventional Pain Physicians, California Medical Association, and the Santa Clara County Medical Association . She has an interest & remains involved in health policy with a background in economics. Dr Singh has been invited and has spoken extensively around the country about the opioid crisis and pain management as well as the growing illicit drug crisis afflicting the nation. Dr Singh's practice uniquely focuses on regional anesthesia and peri-operative, subacute, and the development of chronic pain, with an appreciation on complimentary and traditional medicine approaches that emphasizes an individualized patient-centered approach. She has interests that include public health, persistent pain following surgical procedures, and long term chronic and complex pain issues. Dr. Singh has a background and interest in education for medical students, residents, and fellows. She has identified the growing clinical administrative burden of physicians as a challenge to good patient care, and has spoken about EHR and health IT in general. She strongly believes in a compassionate, individualized patient-centered approach to medicine. She completed a masters in academic medicine as part of her professional development to further enhance leadership, educational curriculum development, interdisciplinary work and various presentations and projects with faculty from around the country. -
Deepti Sinha
Clinical Assistant Professor, Pediatrics - Pulmonary Medicine
BioDr. Sinha is board certified in Pediatrics and Sleep Medicine. She completed medical school in Australia and general pediatric training in Australia and USA at Royal Children’s Hospital and University of Chicago at Illinois. Her sleep medicine fellowship was completed at Stanford Hospital. She enjoys working with children of all ages. She manages both behavioral and physiological sleep concerns.
-
Sidhartha Sinha
Assistant Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsThere are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:
(1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;
(2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain). -
Tammy Lisa Sirich
Assistant Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI conduct translational research focused on uremia and dialysis. I use mass spectrometry to conduct studies testing ways to reduce levels of solutes and examining the contribution of uremic solutes to illness.
-
Davud Sirjani, MD
Clinical Professor, Otolaryngology (Head and Neck Surgery)
Current Research and Scholarly InterestsInnovation of devices to improve the quality of life of patients with advanced head and neck cancers, minimal invasive parotid surgery, surgical simulation, flap reconstruction of large head and neck defects to restore cosmesis and function (speech, swallowing), stem cell recovery of radiation induced salivary damage, and salivary gland cancer biology
-
David Sirkin
Lecturer
BioDavid Sirkin is a Research Associate at Stanford University's Center for Design Research, where he focuses on design methodology, as well as the design of physical interactions between humans and robots, and autonomous vehicles and their interfaces. He is also a Lecturer in Electrical Engineering, where he teaches interactive device design. David frequently collaborates with, and consults for, local Silicon Valley and global technology companies including Siemens, SAP and Microsoft Research. He grew up in Florida, near the Everglades, and in Maine, near the lobsters.
-
Shyam Mohan Sivasankar
Clinical Assistant Professor, Emergency Medicine
BioMy interests lie in the intersection of Medicine and Media, Global Pediatric Emergency Medicine Education, Child Abuse Pediatrics, and in Medical Student Education.
-
Nariman Skakov
Current Research and Scholarly InterestsLate Modernist Experimentation and Stalinist Central Asia
-
Kelley M. Skeff, MD, PhD
George DeForest Barnett Professor of Medicine
Current Research and Scholarly InterestsDevelopment and evaluation of improved teaching methods; assessment of teacher's attitudes toward their teaching role; study of clinical teaching; evaluation of alternative methods of learning in clinical clerkships (e.g. computer assisted instruction, video tape review, etc.).
-
Georgios Skiniotis
Professor of Molecular and Cellular Physiology, of Structural Biology and of Photon Science
BioThe Skiniotis laboratory seeks to resolve structural and mechanistic questions underlying biological processes that are central to cellular physiology. Our investigations employ primarily cryo-electron microscopy (cryoEM) and 3D reconstruction techniques complemented by biochemistry, biophysics and simulation methods to obtain a dynamic view into the macromolecular complexes carrying out these processes. The main theme in the lab is the structural biology of cell surface receptors that mediate intracellular signaling and communication. Our current main focus is the exploration of the mechanisms responsible for transmembrane signal instigation in cytokine receptors and G protein coupled receptor (GPCR) complexes.
-
Eila C. Skinner
Thomas A. Stamey Research Professor of Urology
Current Research and Scholarly InterestsMy research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life.
-
Lawrie Skinner
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
BioDr Skinner is a Board certified therapeutic medical physicist with interests in novel 3D printed devices and a research background in synchrotron x-ray scattering, neutron scattering, molecular dynamics and Monte Carlo computational modelling.
-
Stephen Skirboll
Associate Professor of Neurosurgery
On Leave from 06/24/2024 To 09/06/2024Current Research and Scholarly InterestsMy research focuses on screening strategies to identify and characterize cancer stem cells (CSCs) in human gliomas. We are pursuing this in several ways: 1) a novel colony-forming antibody live cell array to identify distinct CSC surface phenotypes, 2) RNAi screens to identify kinases critical for CSC tumorigenicity, 3) high throughput small molecule and chemical screens to identify compounds that selectively kill or target CSCs, and 4) identifying CSCs using the tumor specific EGFRvIII
